News related to Nexavar (Sorafenib) and/or conditions it is approved for
Sorafenib modestly increases progression-free survival in non-small cell lung cancer
Source: Lung Cancer News From Medical News Today [2015.11.10]
Sorafenib, a tyrosine kinase inhibitor (TKI) targeting the receptors for vascular endothelial growth factor, platelet derived growth factor, and mast/stem cell growth factor, modestly increases...
FDA Approves Nivolumab for Renal Cell Carcinoma
Source: Medscape Nephrology Headlines [2015.11.23]
The immunotherapy is the first treatment to show a survival benefit as a second-line therapy in patients with advanced disease.
FDA approves Opdivo to treat advanced form of kidney cancer
Source: Cancer / Oncology News From Medical News Today [2015.11.24]
The U.S. Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of...